The long-term economic impacts of arthritis through lost productive life years: results from an Australian microsimulation model

BackgroundWhile the direct (medical) costs of arthritis are regularly reported in cost of illness studies, the 'true' cost to indivdiuals and goverment requires the calculation of the indirect costs as well including lost productivity due to ill-health.MethodsRespondents aged 45-64 in the ABS Survey of Disability, Ageing and Carers 2003, 2009 formed the base population. We projected the indirect costs of arthritis using Health&WealthMOD2030 – Australia’s first microsimulation model on the long-term impacts of ill-health in older workers – which incorporated outputs from established microsimulation models (STINMOD and APPSIM), population and labour force projections from Treasury, and chronic conditions trends for Australia. All costs of arthritis were expressed in real 2013 Australian dollars, adjusted for inflation over time.ResultsWe estimated there are 54,000 people aged 45-64 with lost PLYs due to arthritis in 2015, increasing to 61,000 in 2030 (13% increase). In 2015, people with lost PLYs are estimated to receive AU$706.12 less in total income and AU$311.67 more in welfare payments per week than full-time workers without arthritis, and pay no income tax on average. National costs include an estimated loss of AU$1.5 billion in annual income in 2015, increasing to AU$2.4 billion in 2030 (59% increase). Lost annual taxation revenue was projected to increase from AU$0.4 billion in 2015 to $0.5 billion in 2030 (56% increase). We projected a loss in GDP of AU$6.2 billion in 2015, increasing to AU$8.2 billion in 2030.ConclusionsSignificant costs of arthritis through lost PLYs are incurred by individuals and government. The effectiveness of arthritis interventions should be judged not only on healthcare use but quality of life and economic wellbeing.

[1]  Anil Gupta,et al.  Modelling our future : population ageing health and aged care , 2007 .

[2]  T. Trikalinos,et al.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. , 2016, JAMA.

[3]  I. Ackerman,et al.  Counting the cost. Part 1 Healthcare costs: The current and future burden of arthritis , 2016 .

[4]  J. Mp 2015 Intergenerational Report Australia in 2055 , 2015 .

[5]  G. Pransky,et al.  Adapting principles of chronic pain self-management to the workplace , 2012, Disability and rehabilitation.

[6]  R. Shrestha,et al.  Measuring labour productivity and the benefits of interventions for osteoarthritis: Project report for Medicines Australia , 2016 .

[7]  B. Mullan,et al.  An examination of the demographic predictors of adolescent breakfast consumption, content, and context , 2014, BMC Public Health.

[8]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[9]  L. Veerman,et al.  Economic costs of chronic disease through lost productive life years (PLYs) among Australians aged 45–64 years from 2015 to 2030: results from a microsimulation model , 2016, BMJ Open.

[10]  Hai Fang,et al.  Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. , 2009, Arthritis and rheumatism.

[11]  G. Pransky,et al.  Manage at work: a randomized, controlled trial of a self-management group intervention to overcome workplace challenges associated with chronic physical health conditions , 2014, BMC Public Health.

[12]  M. Roberts The Next Chapter in Cost-effectiveness Analysis. , 2016, JAMA.

[13]  Marlene Krasovitsky,et al.  Willing to Work: National Inquiry into Employment Discrimination Against Older Australians and Australians with Disability , 2016 .

[14]  Dan J Stein,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[15]  Labour force participation and the influence of having arthritis on financial status , 2015, Rheumatology International.

[16]  Cluster Analysis on Cohesion Policy Towards Europe 2020 Strategy for Smart, Sustainable and Inclusive Growth , 2015 .

[17]  S. Sheps,et al.  Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[18]  Robert Tanton,et al.  Health&WealthMOD2030: a microsimulation model of the long term economic impacts of disease leading to premature retirements of Australians aged 45-64 years old , 2013 .

[19]  G. Kalb,et al.  Health status and labour force participation: evidence from Australia. , 2006, Health economics.

[20]  Robert Tanton,et al.  Lost productive life years caused by chronic conditions in Australians aged 45–64 years, 2010–2030 , 2015, The Medical journal of Australia.

[21]  A. G. Shaper,et al.  Self-assessment of health status and mortality in middle-aged British men. , 1991, International journal of epidemiology.

[22]  H. Whiteford,et al.  A profile of Australian mental health carers, their caring role and service needs: results from the 2012 Survey of Disability, Ageing and Carers , 2018, Epidemiology and Psychiatric Sciences.

[23]  A. Harding,et al.  Social modelling and public policy: what is microsimulation modelling and how is it being used? , 2002 .

[24]  L. Veerman,et al.  The impact of chronic conditions of care recipients on the labour force participation of informal carers in Australia: which conditions are associated with higher rates of non-participation in the labour force? , 2014, BMC Public Health.

[25]  Alan D. Lopez,et al.  Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors , 2008, The Medical journal of Australia.

[26]  S. Capewell,et al.  Return on investment of public health interventions: a systematic review , 2017, Journal of Epidemiology & Community Health.